Yimei Que

537 total citations
16 papers, 229 citations indexed

About

Yimei Que is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Yimei Que has authored 16 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Yimei Que's work include CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Yimei Que is often cited by papers focused on CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (5 papers). Yimei Que collaborates with scholars based in China and Singapore. Yimei Que's co-authors include Dengju Li, Min Xiao, Xiangmei Liu, Baichuan Wang, Yanli Zhao, Zhicai Zhang, Chuanyu Hu, Hang Liang, Guan Wei and Lei Tan and has published in prestigious journals such as ACS Applied Materials & Interfaces, Frontiers in Immunology and Frontiers in Pharmacology.

In The Last Decade

Yimei Que

16 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yimei Que China	8	109	84	73	60	37	16	229
Juana Serrano‐López Spain	10	129 1.2×	65 0.8×	49 0.7×	71 1.2×	47 1.3×	32	317
Tianhui Liu China	8	92 0.8×	77 0.9×	49 0.7×	22 0.4×	39 1.1×	28	228
Ankit K. Dutta United States	6	194 1.8×	140 1.7×	79 1.1×	38 0.6×	38 1.0×	12	354
Ruixiang Xia China	10	85 0.8×	31 0.4×	58 0.8×	48 0.8×	31 0.8×	25	239
Jennifer Sun United States	9	138 1.3×	126 1.5×	138 1.9×	59 1.0×	146 3.9×	17	373
Riley Allen United States	9	106 1.0×	58 0.7×	36 0.5×	81 1.4×	161 4.4×	11	337
Zhen Jin China	8	117 1.1×	24 0.3×	177 2.4×	134 2.2×	65 1.8×	19	342
Tomasz Sewastianik United States	8	216 2.0×	66 0.8×	96 1.3×	46 0.8×	118 3.2×	16	353
Matthew D. Storck United States	10	151 1.4×	22 0.3×	58 0.8×	16 0.3×	33 0.9×	19	246

Countries citing papers authored by Yimei Que

Since Specialization

Citations

This map shows the geographic impact of Yimei Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimei Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimei Que more than expected).

Fields of papers citing papers by Yimei Que

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimei Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimei Que. The network helps show where Yimei Que may publish in the future.

Co-authorship network of co-authors of Yimei Que

This figure shows the co-authorship network connecting the top 25 collaborators of Yimei Que. A scholar is included among the top collaborators of Yimei Que based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimei Que. Yimei Que is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Huimin, et al.. (2025). CD44v6 CAR-T Cells Target DNMT3A-Mutant AML: Synergistic Enhancement by Decitabine. Current Medical Science. 45(5). 1034–1045. 1 indexed citations

Long, Xiaolu, Ning An, Chunhui Li, et al.. (2024). Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy. Frontiers in Medicine. 11. 1363805–1363805. 1 indexed citations

Liu, Ying, Huimin Li, Yimei Que, et al.. (2024). XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway. Annals of Hematology. 103(7). 2311–2322. 3 indexed citations

Xu, Yanjie, Xia Mao, Yimei Que, et al.. (2023). The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma. BMC Cancer. 23(1). 123–123. 5 indexed citations

Wang, Di, He Li, Chunhui Li, et al.. (2023). Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases. BMC Infectious Diseases. 23(1). 109–109. 2 indexed citations

Li, Zhe, Yimei Que, Di Wang, et al.. (2023). Recovery-model: A model for CAR T-cell-related thrombocytopenia in relapsed/refractory multiple myeloma. Thrombosis Research. 227. 62–70. 2 indexed citations

Wang, Di, Haiying Fu, Yimei Que, et al.. (2023). A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma. Journal of Translational Medicine. 21(1). 812–812. 11 indexed citations

Li, Dan, Yimei Que, Guang Hu, et al.. (2022). Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report. Journal for ImmunoTherapy of Cancer. 10(9). e005403–e005403. 8 indexed citations

Cheng, Yuhang, Di Wang, Menglei Xu, et al.. (2021). Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function. Current Medical Science. 41(3). 474–481. 16 indexed citations

10.

Que, Yimei, Menglei Xu, Yanjie Xu, et al.. (2021). Anti-BCMA CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease: A Single Center Analysis of Two Clinical Trials. Frontiers in Immunology. 12. 755866–755866. 25 indexed citations

11.

Que, Yimei, Huimin Li, Xiaojian Zhu, et al.. (2021). Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation. Frontiers in Immunology. 12. 653030–653030. 23 indexed citations

12.

Hu, Chuanyu, et al.. (2020). Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study. Experimental Hematology and Oncology. 9(1). 29–29. 33 indexed citations

13.

Que, Yimei, et al.. (2020). Exploring the determinants that influence hospital costs of induction therapy for acute myeloid leukemia. Leukemia & lymphoma. 62(5). 1211–1218. 2 indexed citations

14.

Deng, Xiangyu, Guan Wei, Xiangcheng Qing, et al.. (2020). Ultrafast Low-Temperature Photothermal Therapy Activates Autophagy and Recovers Immunity for Efficient Antitumor Treatment. ACS Applied Materials & Interfaces. 12(4). 4265–4275. 69 indexed citations

15.

Que, Yimei, et al.. (2020). Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway. Frontiers in Pharmacology. 11. 21 indexed citations

16.

Wang, Lu, et al.. (2019). Ventricular repolarization dynamics in arsenic trioxide treatment of acute promyelocytic leukemia. International Journal of Cardiology. 306. 163–167. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact